Intraocular pressure is the pressure present inside the eye. The aqueous humour of the ciliary body in the eye is responsible for the intraocular pressure. The production and removal rate of aqueous humour by the ciliary body determines the pressure in the eye. The presence of extra fluid (aqueous humour) builds up pressure in the eye which can lead to glaucoma. There are two types of glaucoma, open–angle glaucoma and closed–angle glaucoma. Generally, tonometers are used for determining the pressure present in the eye.
Global Novel Drugs and Devices to Lower Intraocular Pressure Market Drivers
Approvals of drugs and devices associated with the treatment of glaucoma from regulatory bodies is expected to boost the global novel drugs and devices to lower intraocular pressure market growth. For instance, in May 2019, Ivantis Inc., received an approval from the U.S. Food and Drug Administration (FDA) for Hydrus microstent. It is a device used in minimally invasive glaucoma surgery. It is developed to lower eye pressure in patients with open angle glaucoma.
Furthermore, in September 2018, Sun Pharmaceuticals Industries Ltd. received an approval from U.S. FDA for Xelpros (latanoprost ophthalmic emulsion) for treatment of glaucoma. It reduces the elevated intraocular pressure in the eye and has been designed with the help of Swollen Micelle Micro emulsion technology. Frequent approvals of drugs and devices is expected to accelerate global novel drugs and devices to lower intraocular pressure market growth.
Key players are focused on monitoring post marketing results of approved drugs and devices for the treatment of glaucoma (Intraocular pressure), which is expected to drive the global novel drugs and devices to lower intraocular pressure market growth. For instance, Rhopressa drug manufactured by Aerie Pharmaceuticals was originally approved in December 2017 by U.S. Food and Drug Administration (FDA). The company is now studying the Rhopressa drug (Netarsudil ophthalmic solution) for its pharmacovigilance studies. The drug is being studied for its long-term effects on patients with open angle glaucoma and ocular hypertension. The study is expected to be completed by September 2019. Such developments are expected to drive the global novel drugs and devices to lower intraocular pressure market growth.
Global Novel Drugs and Devices to Lower Intraocular Pressure Market Regional Analysis
North America is expected to be dominant in global novel drugs and devices to lower intraocular pressure market during the forecast period. Factors such as government initiatives expected to augment the North America novel drugs and devices to lower intraocular pressure market growth. For instance, in January 2019, Glaucoma Research Foundation, U.S., formed a team called Catalyst for a Cure. The investigators are working together to understand the exact cause of vision loss in glaucoma patients, and potential targeted therapies for the prevention and treatment of glaucoma. As a result, this factor is expected to support the global novel drugs and devices to lower intraocular pressure market growth.
Global Novel Drugs and Devices to Lower Intraocular Pressure Market Restraints
Side effects of glaucoma medications are expected to hinder growth of the global novel drugs and devices to lower intraocular pressure market. Side effects of medications used for the treatment of glaucoma, such as Rhopressa, include internal bleeding, corneal deposits, and stinging. Also, the cost of these medications is very high. For instance, 2.5 milliliter’s of Rhopressa (Netarsudil ophthalmic solution) costs around US$269. Hence, these factors are expected to restrain the global novel drugs and devices to lower intraocular pressure market growth.
Global Novel Drugs and Devices to Lower Intraocular Pressure Market Key Players
Some of the major players operating in the global novel drugs and devices to lower intraocular pressure market include, Mati Therapeutics Inc, BioLight Lifesciences Ltd., IOPtima Ltd., Eye Sonix, Bausch & Lomb Inc., Sun Pharmaceutical Industries Ltd., Allergan, Alcon Inc., Glaukos Corporation, and Pfizer Inc.
Global Novel Drugs and Devices to Lower Intraocular Pressure Market Taxonomy
The global novel drugs and devices to lower intraocular pressure market is segmented on the basis of treatment, distribution channel, and region.
By Treatment Type
By Distribution Channel
Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:
In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.
Coherent Market Insights desk research is based on a principle set of research techniques:
Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:
Preliminary Data Mining
The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.
Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.
Coherent Statistical model
We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:
Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.
This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:
The primary research is conducted with the ecosystem players including, but not limited to:
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.[email protected]
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.